In five years, each year we've been roughly tripling the output of the facility. We move monto robotic and automation, and we run it like a factory. Light legs, the to day comparative bench marking with a scints ot the bench were about five to ten times cheaper on a per lap operation basis. And that's why we're now able to do millions of designs,. right?
First Jason explains how to deliver great investor updates & the benefits of doing them well (1:36). Then, Ginkgo Bioworks CEO Jason Kelly joins to discuss the expanding capabilities of synthetic biology (24:48), how Ginkgo is currently helping customers make products more effectively (35:58), the ethics & risks of editing DNA (51:53) & more!